1
WGU D116 Advanced Pharmacology Objective Assessment
Actual Exam Questions 200 | 2026/2027 Edition | 100%
Pass Guaranteed | Graded A+
Question 1
A patient with hepatic impairment is prescribed a medication metabolized by the CYP3A4
enzyme. Which pharmacokinetic process is most affected by the patient's condition?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
☑ Correct Answer: C
☑ Explanation: Hepatic impairment directly affects drug metabolism, as the liver is the
primary site of CYP450 enzyme activity. CYP3A4 is a major hepatic enzyme responsible for
metabolizing approximately 50% of all drugs. Reduced liver function decreases metabolic
clearance, prolonging half-life and increasing drug accumulation. Absorption may be affected by
gastrointestinal motility changes but is not the primary concern; distribution relates to protein
binding and tissue penetration; excretion is primarily renal.
,2
Question 2
Which of the following best describes the difference between pharmacokinetics and
pharmacodynamics?
A. Pharmacokinetics is what the body does to the drug; pharmacodynamics is what the drug
does to the body
B. Pharmacodynamics is what the body does to the drug; pharmacokinetics is what the drug
does to the body
C. There is no difference between pharmacokinetics and pharmacodynamics
D. Pharmacokinetics involves drug efficacy; pharmacodynamics involves drug metabolism
☑ Correct Answer: A
☑ Explanation: Pharmacokinetics (ADME) describes how the body affects a drug through
absorption, distribution, metabolism, and excretion. Pharmacodynamics describes the drug's
effects on the body, including receptor binding, mechanism of action, and dose-response
relationships. Option B reverses the definitions. Option C is incorrect as they are distinct
concepts. Option D incorrectly associates efficacy with pharmacokinetics and metabolism with
pharmacodynamics.
,3
Question 3
The "first-pass effect" refers to:
A. Rapid intravenous administration
B. Drug metabolism in the liver before reaching systemic circulation
C. Drug excretion by the kidneys
D. Drug binding to plasma proteins
☑ Correct Answer: B
☑ Explanation: The first-pass effect occurs when orally administered drugs are
metabolized in the liver before reaching systemic circulation, significantly reducing
bioavailability. Drugs such as nitroglycerin, morphine, and propranolol undergo extensive first-
pass metabolism and require higher oral doses or alternative routes. IV administration bypasses
first-pass metabolism entirely. Renal excretion and protein binding are separate
pharmacokinetic processes.
Question 4
Bioavailability is defined as:
, 4
A. The speed of drug absorption
B. The fraction of an administered dose that reaches systemic circulation unchanged
C. The volume of distribution
D. The half-life of the drug
☑ Correct Answer: B
☑ Explanation: Bioavailability measures the proportion of an administered drug dose that
reaches the systemic circulation in unchanged form. IV administration has 100% bioavailability
as it bypasses absorption and first-pass metabolism. Oral bioavailability is reduced by
incomplete absorption and first-pass hepatic metabolism. Option A describes absorption rate, C
describes volume of distribution, and D describes half-life.
Question 5
Which route of administration has the highest bioavailability and fastest onset of action?
A. Oral
B. Subcutaneous
C. Intravenous (IV)
D. Intramuscular (IM)
WGU D116 Advanced Pharmacology Objective Assessment
Actual Exam Questions 200 | 2026/2027 Edition | 100%
Pass Guaranteed | Graded A+
Question 1
A patient with hepatic impairment is prescribed a medication metabolized by the CYP3A4
enzyme. Which pharmacokinetic process is most affected by the patient's condition?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
☑ Correct Answer: C
☑ Explanation: Hepatic impairment directly affects drug metabolism, as the liver is the
primary site of CYP450 enzyme activity. CYP3A4 is a major hepatic enzyme responsible for
metabolizing approximately 50% of all drugs. Reduced liver function decreases metabolic
clearance, prolonging half-life and increasing drug accumulation. Absorption may be affected by
gastrointestinal motility changes but is not the primary concern; distribution relates to protein
binding and tissue penetration; excretion is primarily renal.
,2
Question 2
Which of the following best describes the difference between pharmacokinetics and
pharmacodynamics?
A. Pharmacokinetics is what the body does to the drug; pharmacodynamics is what the drug
does to the body
B. Pharmacodynamics is what the body does to the drug; pharmacokinetics is what the drug
does to the body
C. There is no difference between pharmacokinetics and pharmacodynamics
D. Pharmacokinetics involves drug efficacy; pharmacodynamics involves drug metabolism
☑ Correct Answer: A
☑ Explanation: Pharmacokinetics (ADME) describes how the body affects a drug through
absorption, distribution, metabolism, and excretion. Pharmacodynamics describes the drug's
effects on the body, including receptor binding, mechanism of action, and dose-response
relationships. Option B reverses the definitions. Option C is incorrect as they are distinct
concepts. Option D incorrectly associates efficacy with pharmacokinetics and metabolism with
pharmacodynamics.
,3
Question 3
The "first-pass effect" refers to:
A. Rapid intravenous administration
B. Drug metabolism in the liver before reaching systemic circulation
C. Drug excretion by the kidneys
D. Drug binding to plasma proteins
☑ Correct Answer: B
☑ Explanation: The first-pass effect occurs when orally administered drugs are
metabolized in the liver before reaching systemic circulation, significantly reducing
bioavailability. Drugs such as nitroglycerin, morphine, and propranolol undergo extensive first-
pass metabolism and require higher oral doses or alternative routes. IV administration bypasses
first-pass metabolism entirely. Renal excretion and protein binding are separate
pharmacokinetic processes.
Question 4
Bioavailability is defined as:
, 4
A. The speed of drug absorption
B. The fraction of an administered dose that reaches systemic circulation unchanged
C. The volume of distribution
D. The half-life of the drug
☑ Correct Answer: B
☑ Explanation: Bioavailability measures the proportion of an administered drug dose that
reaches the systemic circulation in unchanged form. IV administration has 100% bioavailability
as it bypasses absorption and first-pass metabolism. Oral bioavailability is reduced by
incomplete absorption and first-pass hepatic metabolism. Option A describes absorption rate, C
describes volume of distribution, and D describes half-life.
Question 5
Which route of administration has the highest bioavailability and fastest onset of action?
A. Oral
B. Subcutaneous
C. Intravenous (IV)
D. Intramuscular (IM)
